Glenn Pierce, Director at Voyager Therapeutics, Inc. (VYGR), bought 5,000 shares at $18.44 ($92K) on 2018-09-12, disclosed to the SEC on 2018-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.